Table of Contents

PART 1: TUMOURS OF THE PITUITARY; Pituitary adenomas; Pituitary carcenoma; Gangliocytoma; Mesenchymal tumours; Granular cell tumours; PART 2: TUMOURS OF THE THYROID AND PARATHYROID; WHO and TNM classifications; Papillary carcinoma; Follicular carcinoma; Poorly differentiated carcinoma; Undifferentiated (anaplastic) carcinoma; Squamous cell carcinoma; Mucoepidermoid carcinoma; Sclerosing mucoepidermoid carcinoma with eosinphilia; Mucinous carcinoma; Medullary thyroid carcinoma; Mixed medullary and follicular cell carcinoma; Spindle cell tumour with thymus-like differentiation; Carcinoma showing thymus-like differentiation; Follicular adenoma; Hyalinizing trabecular tumour; Teratoma; Primary lymphoma and plasmacytoma; Ectopic thymoma; Angiosarcoma; Smooth muscle tumours; Peripheral nerve sheath tumours; Paraganglioma; Solitary fibrous tumour; Rosai-Dorfman disease; Follicular dendritic cell tumour; Langerhans cell histiocytosis; Secondary tumours of the thyroid; Parathyroid carcinoma; Parathyroid adenoma; Secondary tumours of the parathyroid; PART 3: TUMOURS OF THE ADRENAL GLAND; WHO and TNM classifications; Adrenal cortical carcinoma; Adrenal cortical adenoma; Malignant adrenal phaeochromocytoma; Benign phaechromocytoma; Composite phaechromocytoma or paraganglioma; Extra-adrenal paraganglioma; Extra-adrenal sympathetic paragagnlioma; Adenomatoid tumour; Sex cord-stromal tumour; Adrenal soft tissue and germ cell tumours; Secondary tumours; PART 4: TUMOURS OF THE ENDOCRINE TUMOURS; WHO classification; Insulinoma; Glucagonoma; Somatostatinoma; Gastrinoma; VIPoma; Serotonin secreting tumour; ACTH and other ectopic hormone producing tumours; Non-functioning tumours and microadenomas; Mixed exocrine-endocrine carcinomas; Poorly differentiated endocrine carcinoma; PART 5: INHERITED TUMOUR SYNDROMES; Multiple endocrine neoplasia type 2; Mutliple endocrine neoplasia type 1; Hyperparathyroidism-Jaw tumour syndrome; Von Hippel-Lindau syndrome (VHL); Familial paraganglioma-phaechromocytoma syndromes caused by SDHB, SDHC and SDHD mutations; Neurofibromatosis type 1; Carney complex; McCune-Albright syndrome; Familial non-medullary thyroid cancer

About the Author

The International Agency for Research on Cancer (IARC) is part of the World Health Organization. IARC's mission is to coordinate and conduct research on the causes of human cancer, the mechanisms of carcinogenesis, and to develop scientific strategies for cancer control. The Agency is involved in both epidemiological and laboratory research and disseminates scientific information through publications, meetings, courses, and fellowships. Ricardo V. Lloyd